American Gene Technologies International Stock

americangene.comHealthcareFounded: 2007Funding to Date: $72.88MM

American Gene Technologies ("AGT") is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including large and orphan indications, infectious disease, immune-oncology, and monogenic disorders.

Register for Details

For more details on financing and valuation for American Gene Technologies International, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for American Gene Technologies International.

Register Today

Team

Management Team

David Pauza Ph.D
Chief Science Officer
Norman Rogers
Executive, Business Development
Jeffrey Galvin
Co-Founder, Chief Executive Officer & Board Member
Neil Lyons
Chief Financial Officer & Executive Vice President

Board Members

Julia Brown
Qi Tang
Jeffrey Galvin
Aaron Galvin
Tommy Thompson JD

Other companies like American Gene Technologies International in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector